Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSISTENT: Adapted Crohn's Disease Exclusion Diet vs Standard of Care in Adult Crohn's Disease Flare
NCT06953791Phase 2Recruiting
- Sponsor
- University Hospital Tübingen
- Start
- Feb 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Crohn's disease (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Improvement of Quality of Life at 12 weeks. Started Feb 2026; status: recruiting.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06953791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06953791.